Cho, Iksung
Kim, William D.
Kim, Subin
Ko, Kyu-Yong
Seong, Yeonchan
Kim, Dae-Young
Seo, Jiwon
Shim, Chi Young
Ha, Jong-Won
Mori, Makoto
Gupta, Aakriti
You, Seng Chan
Hong, Geu-Ru
Krumholz, Harlan M.
Funding for this research was provided by:
National R&D Program for Cancer Control, Ministry of Health and Welfare, Republic of Korea (HA21C0065)
Yonsei University College of Medicine (6-2021-0142)
Article History
Received: 11 December 2022
Accepted: 17 April 2023
First Online: 24 April 2023
Competing interests
: Dr. Gupta received consulting fees from Arnold and Porter Law Firm, Martin/Baughman Law Firm, and Edwards LifeSciences. In the past three years, Dr. Krumholz received expenses and/or personal fees from UnitedHealth, Element Science, Aetna, Reality Labs, Tesseract/4Catalyst, F-Prime, the Siegfried and Jensen Law Firm, Arnold and Porter Law Firm, and Martin/Baughman Law Firm. He is a co-founder of Refactor Health and HugoHealth, and is associated with contracts, through Yale New Haven Hospital, from the Centers for Medicare and Medicaid Services and through Yale University from Johnson and Johnson. Dr. You is a chief technology officer of PHI Digital Healthcare. Other authors declare no competing interest.